Table of Contents:
  • The surgical and immunosuppressive basis for infections in the pediatric solid organ transplant recipient
  • Immunology recovery and basis for infections in the pediatric hematopoietic stem cell transplant recipient
  • Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient
  • Infectious disease evaluation of infants and children awaiting solid organ or hematopoietic stem cell transplant
  • Donor screening and donor-derived infections
  • Prevention of infections in the hematopoietic stem cell transplant recipient
  • Prevention of infections in the solid organ transplantation recipient
  • Management principles for patients with neutropenia
  • Vaccination issues for transplantation and chemotherapy
  • Microbiome implications in transplantation and oncology
  • Antimicrobial stewardship in immunocompromised hosts
  • Hospital infection prevention for pediatric transplant recipients and oncology patients
  • Safe living after transplantation or chemotherapy
  • Multidrug-resistant gram-negative infections in transplant and oncology patients
  • Bartonella, legionalla, mycoplasma, and ureaplasma
  • Nontuberculous and tuberculous mycobacterium
  • Cytomegalovirus
  • Epstein-Barr virus and posttransplant lymphoproliferative disorder
  • Herpes simplex and varicella-zoster viruses
  • Human herpevirus 6, 7, and 8
  • Respiratory viruses
  • Adenoviruses
  • BK and other polyomavirus associated diseases in children
  • Aspergillosis
  • Mucormycosis, fusariosis, scedosporiases, and other invasive mold diseases
  • Candidiasis
  • Cryptococcosis and other rare invasive yeast infections
  • Histoplasmosis, blastomycosis, and coccidiodomycosis
  • Toxoplasma gondii
  • Nocardia and actinomyces
  • Pneumocystis pneumonia
  • Strongyloides, cryptosporidium, and other parasitic infections
  • Gastrointestinal viruses
  • Clostrdioides difficile infection.